<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9074948" created="22/07/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9074948</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Suppression by <term id="T1" lex="azelastine_hydrochloride" sem="Organic_compound_other">azelastine hydrochloride</term> of <term id="T2" lex="NF-kappa_B_activation" sem="Other"><term id="T3" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> involved in generation of <term id="T4" lex="cytokine" sem="Protein_family_or_group">cytokines</term> and <term id="T5" lex="nitric_oxide" sem="Inorganic_compound">nitric oxide</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T3"/>
<clue>Suppression by azelastine hydrochloride of NF-kappa B <clueType>activation</clueType> involved in generation of cytokines and nitric oxide.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue><clueType>Suppression</clueType> <linkCause>by</linkCause> azelastine hydrochloride <linkTheme>of</linkTheme> NF-kappa B activation involved in generation of cytokines and nitric oxide.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>Suppression by azelastine hydrochloride of NF-kappa B activation involved in <clueType>generation</clueType> <linkTheme>of</linkTheme> cytokines and nitric oxide.</clue>
</event>
<event KT="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<clue>Suppression by azelastine hydrochloride of NF-kappa B activation involved in <clueType>generation</clueType> <linkTheme>of</linkTheme> cytokines and nitric oxide.</clue>
</event>
<event KT="Other" id="E5">
<type class="Correlation"/>
<theme idref="E1"/>
<theme idref="E4"/>
<clue>Suppression by azelastine hydrochloride of NF-kappa B activation <clueType>involved</clueType> <linkTheme>in</linkTheme> generation of cytokines and nitric oxide.</clue>
</event>
<event KT="Other" id="E6">
<type class="Correlation"/>
<theme idref="E1"/>
<theme idref="E3"/>
<clue>Suppression by azelastine hydrochloride of NF-kappa B activation <clueType>involved</clueType> <linkTheme>in</linkTheme> generation of cytokines and nitric oxide.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The influence of the anti-allergy agent <term id="T6" lex="azelastine_hydrochloride" sem="Organic_compound_other">azelastine hydrochloride</term> (<term id="T7" lex="Azeptin" sem="Organic_compound_other">Azeptin</term>) on <term id="T8" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation associated with the generation of <term id="T9" lex="cytokine" sem="Protein_family_or_group">cytokines</term> and <term id="T10" lex="nitric_oxide" sem="Inorganic_compound">nitric oxide</term> (<term id="T11" lex="NO" sem="Inorganic_compound">NO</term>) was investigated in various kinds of <cons id="T12" lex="(AND human_cell mouse_cell)" sem="(AND Cell_natural Cell_natural)"><frag id="F1">human</frag> and <frag id="F2">mouse</frag> <frag id="F3">cells</frag></cons>.</sentence>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>The influence of the anti-allergy agent azelastine hydrochloride (Azeptin) on NF-kappa B <clueType>activation</clueType> associated with the generation of cytokines and nitric oxide (NO) was investigated in various kinds of human and mouse cells.</clue>
</event>
<event KT="Investigation" id="E300" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>The <clueType>influence</clueType> <linkCause>of</linkCause> the <corefTheme>anti-allergy agent</corefTheme> azelastine hydrochloride (Azeptin) <linkTheme>on</linkTheme> NF-kappa B activation associated with the generation of cytokines and nitric oxide (NO) was <clueKT>investigated</clueKT> <clueLoc>in various kinds of human</clueLoc> and mouse <clueLoc>cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E301" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>The <clueType>influence</clueType> <linkCause>of</linkCause> the <corefTheme>anti-allergy agent</corefTheme> azelastine hydrochloride (Azeptin) <linkTheme>on</linkTheme> NF-kappa B activation associated with the generation of cytokines and nitric oxide (NO) was <clueKT>investigated</clueKT> i<clueLoc>n various kinds of</clueLoc> human and <clueLoc>mouse cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>The influence of the anti-allergy agent azelastine hydrochloride (Azeptin) on NF-kappa B activation associated with the <clueType>generation</clueType> <linkTheme>of</linkTheme> cytokines and nitric oxide (NO) was investigated in various kinds of human and mouse cells.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>The influence of the anti-allergy agent azelastine hydrochloride (Azeptin) on NF-kappa B activation associated with the <clueType>generation</clueType> <linkTheme>of</linkTheme> cytokines and nitric oxide (NO) was investigated in various kinds of human and mouse cells.</clue>
</event>
<event KT="Analysis" id="E11">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="E7"/>
<clue>The influence of the anti-allergy agent azelastine hydrochloride (Azeptin) on NF-kappa B activation <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> the generation of cytokines and nitric oxide (NO) was investigated in various kinds of human and mouse cells.</clue>
</event>
<event KT="Analysis" id="E12">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E7"/>
<clue>The influence of the anti-allergy agent azelastine hydrochloride (Azeptin) on NF-kappa B activation <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> the generation of cytokines and nitric oxide (NO) was investigated in various kinds of human and mouse cells.</clue>
</event>
<sentence id="S3"><term id="T13" lex="Azeptin" sem="Organic_compound_other">Azeptin</term> dose-dependently suppressed both <cons id="C1" lex="(AND DNA_synthesis protein_synthesis)" sem="(AND Other Other)"><frag id="F4">DNA</frag> and <frag id="F5">protein</frag> <frag id="F6">synthesis</frag></cons> in <term id="T14" lex="human_gingival_fibroblast" sem="Cell_natural">human gingival fibroblasts</term> (<term id="T15" lex="HF" sem="Cell_natural">HF</term>) and also suppressed <term id="A4" sem="Other">blastogenesis</term> of <term id="T16" lex="human_peripheral_blood_lymphocyte" sem="Cell_natural">human peripheral blood lymphocytes</term> (<term id="T17" lex="PBL" sem="Cell_natural">PBL</term>).</sentence>
<event id="E13">
<type class="Negative_regulation"/>
<theme idref="F4" idref1="F6"/>
<cause idref="T13"/>
<clue>Azeptin dose-dependently <clueType>suppressed</clueType> both DNA and protein synthesis <clueLoc>in human gingival fibroblasts (HF)</clueLoc> and also suppressed blastogenesis of human peripheral blood lymphocytes (PBL).</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="F5" idref1="F6"/>
<cause idref="T13"/>
<clue>Azeptin dose-dependently <clueType>suppressed</clueType> both DNA and protein synthesis <clueLoc>in human gingival fibroblasts (HF)</clueLoc> and also suppressed blastogenesis of human peripheral blood lymphocytes (PBL).</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="A4"/>
<cause idref="T13"/>
<clue>Azeptin dose-dependently suppressed both DNA and protein synthesis in human gingival fibroblasts (HF) and also <clueType>suppressed</clueType> blastogenesis of <clueLoc>human peripheral blood lymphocytes (PBL)</clueLoc>.</clue>
</event>
<sentence id="S4">Generation of <term id="T18" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term>, <term id="T19" lex="interleukin_1-beta" sem="Protein_molecule">interleukin 1-beta</term>, <term id="T20" lex="granulocyte-macrophage_colony-stimulating_factor" sem="Protein_molecule">granulocyte-macrophage colony-stimulating factor</term> and <term id="T21" lex="interleukin-6" sem="Protein_molecule">interleukin-6</term> from 10(-5) M <term id="T22" lex="Azeptin" sem="Organic_compound_other">Azeptin</term>-treated <term id="T23" lex="PBL" sem="Cell_natural">PBL</term> and <term id="T24" lex="human_monocyte" sem="Cell_natural">human monocytes</term> (<term id="T25" lex="HM" sem="Cell_natural">HM</term>) was decreased to approximately 1/3 to 2/3 of the control levels.</sentence>
<event id="E16">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue><clueType>Generation</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and human monocytes (HM) was decreased to approximately 1/3 to 2/3 of the control levels.</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="T19"/>
<clue><clueType>Generation</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and human monocytes (HM) was decreased to approximately 1/3 to 2/3 of the control levels.</clue>
</event>
<event id="E18">
<type class="Gene_expression"/>
<theme idref="T20"/>
<clue><clueType>Generation</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and human monocytes (HM) was decreased to approximately 1/3 to 2/3 of the control levels.</clue>
</event>
<event id="E19">
<type class="Gene_expression"/>
<theme idref="T21"/>
<clue><clueType>Generation</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and human monocytes (HM) was decreased to approximately 1/3 to 2/3 of the control levels.</clue>
</event>
<event Manner="Low" id="E310">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated <clueLoc>PBL</clueLoc> and human monocytes (HM) was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E311">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and <clueLoc>human monocytes (HM)</clueLoc> was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E312">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated <clueLoc>PBL</clueLoc> and human monocytes (HM) was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E313">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and <clueLoc>human monocytes (HM)</clueLoc> was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E314">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated <clueLoc>PBL</clueLoc> and human monocytes (HM) was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E315">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and <clueLoc>human monocytes (HM)</clueLoc> was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E316">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated <clueLoc>PBL</clueLoc> and human monocytes (HM) was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<event Manner="Low" id="E317">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T22"/>
<clue>Generation of tumor necrosis factor-alpha, interleukin 1-beta, granulocyte-macrophage colony-stimulating factor and interleukin-6 from 10(-5) M Azeptin-treated PBL and <clueLoc>human monocytes (HM)</clueLoc> was <clueType>decreased</clueType> <clueManner>to approximately 1/3 to 2/3</clueManner> of the control levels.</clue>
</event>
<sentence id="S5">In parallel with the decreased <term id="T26" lex="cytokine_generation" sem="Other"><term id="T27" lex="cytokine" sem="Protein_family_or_group">cytokine</term> generation</term>, each <term id="T28" lex="cytokine_mRNA" sem="RNA_molecule"><term id="T29" lex="cytokine" sem="Protein_family_or_group">cytokine</term> mRNA</term> was less expressed in the presence of 10(-5) M <term id="T30" lex="Azeptin" sem="Organic_compound_other">Azeptin</term>.</sentence>
<event id="E24">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>In parallel with the decreased cytokine <clueType>generation</clueType>, each cytokine mRNA was less expressed in the presence of 10(-5) M Azeptin.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T30"/>
<clue>In parallel with the <clueType>decreased</clueType> cytokine generation, each cytokine mRNA was less expressed <linkCause>in the presence of</linkCause> 10(-5) M Azeptin.</clue>
</event>
<event id="E26">
<type class="Transcription"/>
<theme idref="T28"/>
<clue>In parallel with the decreased cytokine generation, each cytokine mRNA was less <clueType>expressed</clueType> in the presence of 10(-5) M Azeptin.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T30"/>
<clue>In parallel with the decreased cytokine generation, each cytokine mRNA was <clueType>less</clueType> expressed <linkCause>in the presence of</linkCause> 10(-5) M Azeptin.</clue>
</event>
<sentence id="S6">In addition, both inducible <term id="T31" lex="nitric_oxide_synthase-mRNA_level" sem="Other"><term id="A5" sem="RNA_molecule"><term id="T32" lex="nitric_oxide_synthase" sem="Protein_molecule">nitric oxide synthase</term>-mRNA</term> level</term> and <term id="T33" lex="NO_generation" sem="Other"><term id="A6" lex="NO" sem="Inorganic_compound">NO</term> generation</term> in <term id="T34" lex="mouse_peritoneal_macrophage" sem="Cell_natural">mouse peritoneal macrophages</term> were suppressed by 10(-5) M <term id="T35" lex="Azeptin" sem="Organic_compound_other">Azeptin</term>.</sentence>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<clue>In addition, both inducible nitric oxide synthase-mRNA level and NO <clueType>generation</clueType> <clueLoc>in mouse peritoneal macrophages</clueLoc> were suppressed by 10(-5) M Azeptin.</clue>
</event>
<event KT="Other" id="E29">
<type class="Transcription"/>
<theme idref="A5"/>
<clue>In addition, both <clueType>inducible</clueType> nitric oxide synthase-mRNA <clueType>level</clueType> and NO generation <clueLoc>in mouse peritoneal macrophages</clueLoc> were suppressed by 10(-5) M Azeptin.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T35"/>
<clue>In addition, both inducible nitric oxide synthase-mRNA level and NO generation in mouse peritoneal macrophages were <clueType>suppressed</clueType> <linkCause>by</linkCause> 10(-5) M Azeptin.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T35"/>
<clue>In addition, both inducible nitric oxide synthase-mRNA level and NO generation in mouse peritoneal macrophages were <clueType>suppressed</clueType> <linkCause>by</linkCause> 10(-5) M Azeptin.</clue>
</event>
<sentence id="S7">Being compatible with those results, <term id="T36" lex="Azeptin" sem="Organic_compound_other">Azeptin</term> (10(-5) M) suppressed activation of <term id="T37" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> in <term id="T38" lex="PBL" sem="Cell_natural">PBL</term>, HM and <term id="T39" lex="HF" sem="Cell_natural">HF</term>.</sentence>
<event KT="Other" id="E32">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>Being compatible with those results, Azeptin (10(-5) M) suppressed <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B in PBL, HM and HF.</clue>
</event>
<event id="E320">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T36"/>
<clue>Being compatible with those results, Azeptin (10(-5) M) <clueType>suppressed</clueType> activation of NF-kappa B <clueLoc>in PBL</clueLoc>, HM and HF.</clue>
</event>
<event id="E321">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T36"/>
<clue>Being compatible with those results, Azeptin (10(-5) M) <clueType>suppressed</clueType> activation of NF-kappa B <clueLoc>in</clueLoc> PBL, <clueLoc>HM</clueLoc> and HF.</clue>
</event>
<event id="E322">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T36"/>
<clue>Being compatible with those results, Azeptin (10(-5) M) <clueType>suppressed</clueType> activation of NF-kappa B <clueLoc>in</clueLoc> PBL, HM and <clueLoc>HF</clueLoc>.</clue>
</event>
<sentence id="S8">These results appear to indicate that suppression of <term id="T40" lex="cytokine" sem="Protein_family_or_group">cytokine</term> and <term id="T41" lex="NO" sem="Inorganic_compound">NO</term> generation by <term id="T42" lex="Azeptin" sem="Organic_compound_other">Azeptin</term> results at least partially from the inhibition of <term id="T43" lex="NF-kappa_B_activation" sem="Other"><term id="T44" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E34">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>These results appear to indicate that suppression of cytokine and NO <clueType>generation</clueType> by Azeptin results at least partially from the inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<clue>These results appear to indicate that suppression of cytokine and NO <clueType>generation</clueType> by Azeptin results at least partially from the inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E36">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T42"/>
<clue>These results appear to indicate that <clueType>suppression</clueType> <linkTheme>of</linkTheme> cytokine and NO generation <linkCause>by</linkCause> Azeptin results at least partially from the inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E37">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="T42"/>
<clue>These results appear to indicate that <clueType>suppression</clueType> <linkTheme>of</linkTheme> cytokine and NO generation <linkCause>by</linkCause> Azeptin results at least partially from the inhibition of NF-kappa B activation.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<clue>These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E39">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<clue>These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E40" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E39"/>
<clue>These results <clueCL>appear</clueCL> to <clueKT>indicate</clueKT> that suppression of cytokine and NO generation by Azeptin <clueType>results</clueType> at least partially <linkCause>from</linkCause> the inhibition of NF-kappa B activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E41" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E39"/>
<clue>These results <clueCL>appear</clueCL> to <clueKT>indicate</clueKT> that suppression of cytokine and NO generation by Azeptin <clueType>results</clueType> at least partially <linkCause>from</linkCause> the inhibition of NF-kappa B activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
